Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

70.93 10.51 −12.91%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a

Globus Medical, Inc. 8-K filed Nov 5, 2026

Period ended Nov 5, 2026 · Filed · accepted 4:09 PM ET · Document on sec.gov · Filing index

2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits

This 8-K released the latest quarter’s results. Read Earnings & Analysis